C. Xu

Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation

Bo Zhang, C. Xu, Yun Shao et al. · Experimental and Therapeutic Medicine · 2015 · 102 citations · Full text

Medicine, Molecular Biology, Oncology +17

TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma

Wenjing Xiao, Nan Du, Taoyuan Huang et al. · EBioMedicine · 2018 · 84 citations · Full text

Medicine, Molecular Genetics, Oncology +17

TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib

Wenxian Wang, C. Xu, Yanping Chen et al. · Journal of Thoracic Disease · 2018 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study

Wenxian Wang, C. Xu, Huafei Chen et al. · Lung Cancer · 2021 · 68 citations

Medicine, Molecular Genetics, Oncology +17

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial

Zhengbo Song, Yuping Li, Shiqing Chen et al. · BMC Medicine · 2022 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17